MAPT and Alzheimer disease: They found that LMTK2 expression was significantly reduced in neurofibrillary tangle-affected regions and showed a strong inverse correlation with phospho-tau levels, indicating that decreased LMTK2 is associated with tau pathology rather than a general feature of AD brains [71].